Krystal Biotech, Inc.
KRYS · Biological Products, (No Diagnostic Substances) · 29.5M shares · +10%/yr ↑ shares · EDGAR filings ↗
Reference price $300.75 · est. market cap ~$8.9B — last insider sale, 2026-06-04 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
A87Profitable, cash-generative gene-therapy franchise with an approved, globally launching product and top-decile margins and returns.
Strengths
- Top-decile profitability: net margin 53%, operating margin 41%, FCF margin 49% (all ~100 pct), FCF +$189M
- VYJUVEK approved in US/EU/Japan with positive, internally controlled Phase 3 data; revenue +34%
- Proprietary redosable HSV-1 platform with FDA platform designation and a deep pipeline; $956M cash
Risks
- Substantial dependence on a single commercial product (VYJUVEK)
- Pipeline execution, manufacturing, and reimbursement risks as it scales internationally
Notable findings
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
- Strong balance sheetStrong balance sheet — $956M cash & investments
- Notable holderHeld by 6 notable fund(s): FMR LLC, STATE STREET CORP, GOLDMAN SACHS GROUP INC +3 more (as of 2026-03-31)
- Insider sellingInsider selling — 75 open-market sale(s) by 6 insider(s) (cluster of 6 insiders, ~$57M, last 6mo) Form 4 ↗
- Trial readout soonUpcoming trial readout ~2026-12 — PHASE1/PHASE2 · Neurotrophic Keratitis
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Operating margin
41.5%
Net margin
52.6%
Return on equity
16.8%
Return on assets
15.4%
Revenue growth (QoQ)
8.6%
Net-income growth
129.7%
Current ratio
10.0×
Free cash flow
$189M
Tangible book value
$1.2B
Cash & investments
$956M
Stock comp / revenue
14.0%
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-04 | Krishnan Suma | Sell | 3.8K | $308.89 |
| 2026-06-04 | Krishnan Suma | Sell | 480 | $305.87 |
| 2026-06-04 | Krishnan Suma | Sell | 2.8K | $309.95 |
| 2026-06-04 | Krishnan Suma | Sell | 2.0K | $310.94 |
| 2026-06-04 | Krishnan Suma | Sell | 240 | $311.65 |
| 2026-06-04 | Krishnan Krish S | Sell | 320 | $300.75 |
| 2026-06-04 | Krishnan Krish S | Sell | 640 | $302.24 |
| 2026-06-04 | Krishnan Suma | Sell | 320 | $300.75 |
| 2026-06-04 | Krishnan Krish S | Sell | 176 | $303.17 |
| 2026-06-04 | Krishnan Krish S | Sell | 544 | $304.81 |
| 2026-06-04 | Krishnan Krish S | Sell | 589 | $306.33 |
| 2026-06-04 | Krishnan Krish S | Sell | 11K | $307.68 |
| 2026-06-04 | Krishnan Suma | Sell | 247 | $303.17 |
| 2026-06-04 | Krishnan Krish S | Sell | 4.8K | $308.47 |
| 2026-06-04 | Krishnan Krish S | Sell | 2.8K | $309.49 |
| 2026-06-04 | Krishnan Suma | Sell | 1.3K | $307.09 |
| 2026-06-04 | Krishnan Krish S | Sell | 2.7K | $310.43 |
| 2026-06-04 | Krishnan Krish S | Sell | 964 | $311.36 |
| 2026-06-04 | Krishnan Krish S | Sell | 40 | $312.23 |
| 2026-06-04 | Krishnan Suma | Sell | 593 | $302.25 |
| 2026-06-04 | Krishnan Suma | Sell | 13K | $307.81 |
| 2026-06-04 | Krishnan Suma | Sell | 400 | $304.89 |
| 2026-05-26 | Thomas John Charles | Sell | 642 | $302.03 |
| 2026-03-04 | Krishnan Krish S | Sell | 2.4K | $262.44 |
| 2026-03-04 | Krishnan Suma | Sell | 407 | $257.32 |
| 2026-03-04 | Krishnan Suma | Sell | 589 | $258.54 |
| 2026-03-04 | Krishnan Suma | Sell | 668 | $259.61 |
| 2026-03-04 | Krishnan Suma | Sell | 3.7K | $260.37 |
| 2026-03-04 | Krishnan Suma | Sell | 2.9K | $261.41 |
| 2026-03-04 | Krishnan Suma | Sell | 1.9K | $262.35 |
| 2026-03-04 | Krishnan Suma | Sell | 2.2K | $263.58 |
| 2026-03-04 | Krishnan Suma | Sell | 4.9K | $264.64 |
| 2026-03-04 | Krishnan Suma | Sell | 6.0K | $265.16 |
| 2026-03-04 | Krishnan Suma | Sell | 1.7K | $266.42 |
| 2026-03-04 | Krishnan Krish S | Sell | 483 | $257.31 |
| 2026-03-04 | Krishnan Krish S | Sell | 470 | $258.38 |
| 2026-03-04 | Krishnan Krish S | Sell | 1.4K | $259.87 |
| 2026-03-04 | Krishnan Krish S | Sell | 3.1K | $260.49 |
| 2026-03-04 | Krishnan Krish S | Sell | 3.0K | $261.41 |
| 2026-03-04 | Krishnan Krish S | Sell | 2.0K | $263.70 |
| 2026-03-04 | Krishnan Krish S | Sell | 8.8K | $264.85 |
| 2026-03-04 | Krishnan Krish S | Sell | 2.4K | $265.59 |
| 2026-03-04 | Krishnan Krish S | Sell | 920 | $266.56 |
| 2026-03-02 | ROMANO KATHRYN | Sell | 750 | $267.60 |
| 2026-02-27 | Krishnan Krish S | Tax withheld | 2.6K | $275.64 |
| 2026-02-27 | ROMANO KATHRYN | Option exercise | 7.5K | — |
| 2026-02-27 | ROMANO KATHRYN | Tax withheld | 3.3K | $275.64 |
| 2026-02-27 | ROMANO KATHRYN | Option exercise | 550 | — |
| 2026-02-27 | ROMANO KATHRYN | Tax withheld | 240 | $275.64 |
| 2026-02-27 | JANNEY DANIEL | Sell | 9.4K | $275.45 |
| 2026-02-27 | JANNEY DANIEL | Sell | 2.4K | $276.17 |
| 2026-02-27 | Krishnan Suma | Option exercise | 22K | — |
| 2026-02-27 | Krishnan Suma | Tax withheld | 10K | $275.64 |
| 2026-02-27 | Krishnan Suma | Option exercise | 4.0K | — |
| 2026-02-27 | Krishnan Suma | Tax withheld | 1.8K | $275.64 |
| 2026-02-27 | Krishnan Suma | Option exercise | 8.8K | — |
| 2026-02-27 | Krishnan Suma | Tax withheld | 4.0K | $275.64 |
| 2026-02-27 | Krishnan Suma | Option exercise | 26K | — |
| 2026-02-27 | Krishnan Suma | Tax withheld | 12K | $275.64 |
| 2026-02-27 | Krishnan Suma | Option exercise | 5.7K | — |
| 2026-02-27 | Krishnan Suma | Tax withheld | 2.6K | $275.64 |
| 2026-02-27 | Krishnan Krish S | Option exercise | 8.8K | — |
| 2026-02-27 | Krishnan Krish S | Tax withheld | 4.0K | $275.64 |
| 2026-02-27 | Krishnan Krish S | Option exercise | 26K | — |
| 2026-02-27 | Krishnan Krish S | Tax withheld | 12K | $275.64 |
| 2026-02-27 | Krishnan Krish S | Option exercise | 5.7K | — |
| 2026-02-27 | Krishnan Krish S | Option exercise | 22K | — |
| 2026-02-27 | Krishnan Krish S | Tax withheld | 10K | $275.64 |
| 2026-02-27 | Krishnan Krish S | Option exercise | 4.0K | — |
| 2026-02-27 | Krishnan Krish S | Tax withheld | 1.8K | $275.64 |
| 2026-02-26 | JANNEY DANIEL | Sell | 5.1K | $275.28 |
| 2026-02-26 | JANNEY DANIEL | Sell | 2.6K | $276.32 |
| 2026-02-25 | JANNEY DANIEL | Sell | 700 | $275.00 |
| 2026-02-24 | JANNEY DANIEL | Sell | 3.6K | $265.08 |
| 2026-02-24 | JANNEY DANIEL | Sell | 9.0K | $266.18 |
| 2026-02-24 | JANNEY DANIEL | Sell | 12K | $266.97 |
| 2026-02-24 | JANNEY DANIEL | Sell | 6.7K | $268.04 |
| 2026-02-24 | JANNEY DANIEL | Sell | 4.0K | $268.97 |
| 2026-02-24 | JANNEY DANIEL | Sell | 370 | $269.83 |
| 2026-02-24 | JANNEY DANIEL | Sell | 373 | $271.09 |
| 2026-02-24 | JANNEY DANIEL | Sell | 62 | $263.05 |
| 2026-02-24 | JANNEY DANIEL | Sell | 900 | $264.60 |
| 2026-02-24 | JANNEY DANIEL | Sell | 1.6K | $265.54 |
| 2026-02-24 | JANNEY DANIEL | Sell | 4.3K | $266.62 |
| 2026-02-24 | JANNEY DANIEL | Sell | 1.9K | $267.37 |
| 2026-02-24 | JANNEY DANIEL | Sell | 1.7K | $268.67 |
| 2026-02-24 | JANNEY DANIEL | Sell | 930 | $269.50 |
| 2026-02-24 | JANNEY DANIEL | Sell | 2.4K | $274.90 |
| 2026-02-24 | JANNEY DANIEL | Option exercise | 38K | $2.46 |
| 2026-02-24 | JANNEY DANIEL | Sell | 569 | $262.91 |
| 2026-02-24 | JANNEY DANIEL | Sell | 1.7K | $264.12 |
| 2026-02-19 | ROSSI DINO A | Option exercise | 19K | $8.79 |
| 2026-02-19 | ROSSI DINO A | Sell | 8.1K | $260.49 |
| 2026-02-19 | ROSSI DINO A | Sell | 11K | $262.10 |
| 2026-02-09 | ROMANO KATHRYN | Option exercise | 12K | $63.55 |
| 2026-02-09 | ROMANO KATHRYN | Sell | 2.0K | $270.56 |
| 2026-02-09 | ROMANO KATHRYN | Sell | 5.7K | $271.66 |
| 2026-02-09 | ROMANO KATHRYN | Sell | 2.8K | $272.51 |
| 2026-02-09 | ROMANO KATHRYN | Sell | 928 | $273.71 |
| 2026-02-09 | ROMANO KATHRYN | Sell | 552 | $274.64 |
| 2026-02-09 | ROMANO KATHRYN | Sell | 400 | $275.68 |
| 2026-02-09 | ROMANO KATHRYN | Sell | 96 | $277.88 |
| 2026-02-09 | ROMANO KATHRYN | Gift | 750 | — |
| 2025-12-05 | Krishnan Krish S | Gift | 5.0K | — |
| 2025-12-05 | Krishnan Suma | Gift | 5.0K | — |
| 2025-12-04 | Krishnan Krish S | Sell | 10K | $221.82 |
| 2025-12-04 | Krishnan Suma | Sell | 700 | $214.25 |
| 2025-12-04 | Krishnan Suma | Sell | 600 | $215.49 |
| 2025-12-04 | Krishnan Suma | Sell | 1.4K | $216.97 |
| 2025-12-04 | Krishnan Suma | Sell | 3.6K | $218.83 |
| 2025-12-04 | Krishnan Suma | Sell | 5.4K | $219.68 |
| 2025-12-04 | Krishnan Suma | Sell | 2.6K | $220.52 |
| 2025-12-04 | Krishnan Suma | Sell | 10K | $221.82 |
| 2025-12-04 | Krishnan Suma | Sell | 200 | $222.38 |
| 2025-12-04 | Krishnan Suma | Sell | 956 | $214.28 |
| 2025-12-04 | Krishnan Suma | Sell | 344 | $215.48 |
| 2025-12-04 | Krishnan Suma | Sell | 1.6K | $217.04 |
| 2025-12-04 | Krishnan Suma | Sell | 2.6K | $218.72 |
| 2025-12-04 | Krishnan Suma | Sell | 5.7K | $219.53 |
| 2025-12-04 | Krishnan Suma | Sell | 2.6K | $220.34 |
| 2025-12-04 | Krishnan Suma | Sell | 11K | $221.78 |
| 2025-12-04 | Krishnan Suma | Sell | 700 | $222.20 |
| 2025-12-04 | Krishnan Krish S | Sell | 956 | $214.28 |
| 2025-12-04 | Krishnan Krish S | Sell | 344 | $215.48 |
| 2025-12-04 | Krishnan Krish S | Sell | 1.6K | $217.04 |
| 2025-12-04 | Krishnan Krish S | Sell | 2.6K | $218.72 |
| 2025-12-04 | Krishnan Krish S | Sell | 5.7K | $219.55 |
| 2025-12-04 | Krishnan Krish S | Sell | 2.6K | $220.34 |
| 2025-12-04 | Krishnan Krish S | Sell | 11K | $221.78 |
| 2025-12-04 | Krishnan Krish S | Sell | 700 | $222.20 |
| 2025-12-04 | Krishnan Krish S | Sell | 700 | $214.25 |
| 2025-12-04 | Krishnan Krish S | Sell | 600 | $215.49 |
| 2025-12-04 | Krishnan Krish S | Sell | 1.4K | $216.97 |
| 2025-12-04 | Krishnan Krish S | Sell | 3.6K | $218.83 |
| 2025-12-04 | Krishnan Krish S | Sell | 5.4K | $219.68 |
| 2025-12-04 | Krishnan Krish S | Sell | 2.6K | $220.52 |
| 2025-12-04 | Krishnan Krish S | Sell | 200 | $222.38 |
| 2025-07-16 | Krishnan Suma | Sell | 1.4K | $150.00 |
| 2025-07-16 | Krishnan Suma | Sell | 1.5K | $150.00 |
| 2025-07-16 | Krishnan Krish S | Sell | 1.5K | $150.00 |
| 2025-07-16 | Krishnan Krish S | Sell | 1.4K | $150.00 |
| 2025-07-15 | Krishnan Suma | Sell | 2.2K | $150.68 |
| 2025-07-15 | Krishnan Suma | Sell | 900 | $151.79 |
| 2025-07-15 | Krishnan Suma | Sell | 800 | $151.79 |
| 2025-07-15 | Krishnan Krish S | Sell | 2.2K | $150.68 |
| 2025-07-15 | Krishnan Krish S | Sell | 900 | $151.79 |
| 2025-07-15 | Krishnan Suma | Sell | 2.2K | $150.68 |
| 2025-07-15 | Krishnan Krish S | Sell | 2.2K | $150.68 |
| 2025-07-15 | Krishnan Krish S | Sell | 800 | $151.79 |
| 2025-07-14 | Krishnan Suma | Sell | 13K | $150.29 |
| 2025-07-14 | Krishnan Suma | Sell | 100 | $151.00 |
| 2025-07-14 | Krishnan Suma | Sell | 13K | $150.30 |
| 2025-07-14 | Krishnan Krish S | Sell | 13K | $150.30 |
| 2025-07-14 | Krishnan Krish S | Sell | 13K | $150.29 |
| 2025-07-14 | Krishnan Krish S | Sell | 100 | $151.00 |
| 2025-07-10 | Krishnan Krish S | Sell | 300 | $151.39 |
| 2025-07-10 | Krishnan Suma | Sell | 6.5K | $150.23 |
| 2025-07-10 | Krishnan Krish S | Sell | 6.5K | $150.23 |
| 2025-07-10 | Krishnan Krish S | Sell | 300 | $151.39 |
| 2025-07-10 | Krishnan Suma | Sell | 6.6K | $150.22 |
| 2025-07-10 | Krishnan Suma | Sell | 300 | $151.39 |
| 2025-07-10 | Krishnan Suma | Sell | 300 | $151.39 |
| 2025-07-10 | Krishnan Krish S | Sell | 6.6K | $150.22 |
| 2025-07-09 | Krishnan Krish S | Sell | 200 | $150.07 |
| 2025-07-09 | Krishnan Suma | Sell | 200 | $150.07 |
| 2025-07-09 | Krishnan Suma | Sell | 200 | $150.14 |
| 2025-07-09 | Krishnan Krish S | Sell | 200 | $150.14 |
| 2025-03-13 | Krishnan Suma | Sell | 1.6K | $175.97 |
| 2025-03-13 | Krishnan Suma | Sell | 4.6K | $176.88 |
| 2025-03-13 | Krishnan Suma | Sell | 11K | $177.66 |
| 2025-03-13 | Krishnan Suma | Sell | 6.5K | $178.76 |
| 2025-03-13 | Krishnan Suma | Sell | 1.3K | $179.55 |
| 2025-03-13 | Krishnan Suma | Sell | 1.1K | $175.83 |
| 2025-03-13 | Krishnan Suma | Sell | 4.9K | $176.80 |
| 2025-03-13 | Krishnan Suma | Sell | 11K | $177.62 |
| 2025-03-13 | Krishnan Suma | Sell | 6.8K | $178.77 |
| 2025-03-13 | Krishnan Suma | Sell | 1.3K | $179.57 |
| 2025-03-13 | Krishnan Krish S | Sell | 1.1K | $175.83 |
| 2025-03-13 | Krishnan Krish S | Sell | 4.9K | $176.80 |
| 2025-03-13 | Krishnan Krish S | Sell | 11K | $177.62 |
| 2025-03-13 | Krishnan Krish S | Sell | 6.8K | $178.77 |
| 2025-03-13 | Krishnan Krish S | Sell | 1.3K | $179.57 |
| 2025-03-13 | Krishnan Krish S | Sell | 1.6K | $175.97 |
| 2025-03-13 | Krishnan Krish S | Sell | 4.6K | $176.88 |
| 2025-03-13 | Krishnan Krish S | Sell | 11K | $177.66 |
| 2025-03-13 | Krishnan Krish S | Sell | 6.5K | $178.76 |
| 2025-03-13 | Krishnan Krish S | Sell | 1.3K | $179.55 |
| 2025-02-28 | Krishnan Krish S | Tax withheld | 12K | $179.25 |
| 2025-02-28 | Krishnan Krish S | Tax withheld | 3.5K | $179.25 |
| 2025-02-28 | Krishnan Krish S | Option exercise | 22K | — |
| 2025-02-28 | Krishnan Krish S | Tax withheld | 10K | $179.25 |
| 2025-02-28 | ROMANO KATHRYN | Option exercise | 7.5K | — |
| 2025-02-28 | ROMANO KATHRYN | Tax withheld | 3.5K | $179.25 |
| 2025-02-28 | Krishnan Krish S | Option exercise | 7.5K | — |
| 2025-02-28 | Krishnan Suma | Option exercise | 7.5K | — |
| 2025-02-28 | Krishnan Suma | Tax withheld | 3.5K | $179.25 |
| 2025-02-28 | Krishnan Suma | Option exercise | 22K | — |
| 2025-02-28 | Krishnan Suma | Tax withheld | 10K | $179.25 |
| 2025-02-28 | Krishnan Suma | Option exercise | 12K | — |
| 2025-02-28 | Krishnan Suma | Tax withheld | 5.8K | $179.25 |
| 2025-02-28 | Krishnan Suma | Option exercise | 8.8K | — |
| 2025-02-28 | Krishnan Suma | Tax withheld | 4.0K | $179.25 |
| 2025-02-28 | Krishnan Suma | Option exercise | 26K | — |
| 2025-02-28 | Krishnan Suma | Tax withheld | 12K | $179.25 |
| 2025-02-28 | ROMANO KATHRYN | Option exercise | 5.0K | — |
| 2025-02-28 | ROMANO KATHRYN | Tax withheld | 2.3K | $179.25 |
| 2025-02-28 | Krishnan Krish S | Option exercise | 12K | — |
| 2025-02-28 | Krishnan Krish S | Tax withheld | 5.8K | $179.25 |
| 2025-02-28 | Krishnan Krish S | Option exercise | 8.8K | — |
| 2025-02-28 | Krishnan Krish S | Tax withheld | 4.0K | $179.25 |
| 2025-02-28 | Krishnan Krish S | Option exercise | 26K | — |
| 2025-02-27 | ROMANO KATHRYN | Sell | 750 | $175.22 |
| 2025-02-26 | Krishnan Krish S | Tax withheld | 3.3K | $176.39 |
| 2025-02-26 | Krishnan Suma | Tax withheld | 3.3K | $176.39 |
| 2025-02-26 | Krishnan Suma | Tax withheld | 4.7K | $176.39 |
| 2025-02-26 | Krishnan Krish S | Tax withheld | 4.7K | $176.39 |
| 2025-02-26 | ROMANO KATHRYN | Tax withheld | 2.3K | $176.39 |
All non-derivative Form 4 activity (SEC), newest first.
Clinical trials
| Trial | Title | Phase | Status | Primary completion |
|---|---|---|---|---|
| NCT04917887 ↗ | Long-Term Follow-up Protocol Dystrophic Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa | — | Recruiting | 2028-05-25 |
| NCT05970497 ↗ | A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors Cancer, Melanoma Stage III | PHASE1/PHASE2 | Recruiting | 2027-07-01 |
| NCT06228326 ↗ | A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs Lung Cancer, Non-small Cell, Lung Cancer Metastatic | PHASE1/PHASE2 | Recruiting | 2027-02-01 |
| NCT07016750 ↗ | A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa Dystrophic Epidermolysis Bullosa, DEB - Dystrophic Epidermolysis Bullosa | PHASE3 | Recruiting | 2026-12-01 |
| NCT06999733 ↗ | A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis Neurotrophic Keratitis | PHASE1/PHASE2 | Recruiting | 2026-12-01 |
| NCT05504837 ↗ | A Study Assessing KB407 for the Treatment of Cystic Fibrosis Cystic Fibrosis | PHASE1 | Recruiting | 2026-12-01 |
| NCT06049082 ↗ | A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency Alpha 1-Antitrypsin Deficiency | PHASE1 | Recruiting | 2025-12-01 |
| NCT06563414 ↗ | A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB) Epidermolysis Bullosa Dystrophica, Epidermolysis Bullosa Dystrophica, Recessive | — | Recruiting | 2025-12-01 |
| NCT06724900 ↗ | A Study Assessing KB304 for the Treatment of Wrinkles in Women Wrinkles in Decolletage, Pigmentation | PHASE1/PHASE2 | Active Not Recruiting | 2025-07-01 |
| NCT04540900 ↗ | A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions Skin Roughness, Wrinkle | PHASE1 | Active Not Recruiting | 2024-10-16 |
| NCT05095246 ↗ | A Study of Inhaled KB407 for the Treatment of Cystic Fibrosis Cystic Fibrosis | PHASE1 | Withdrawn | 2024-07-01 |
| NCT05735158 ↗ | Topical KB105 for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI) Autosomal Recessive Ichthyosis | PHASE2 | Unknown | 2024-03-01 |
| NCT04917874 ↗ | A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa Dystrophic Epidermolysis Bullosa, DEB - Dystrophic Epidermolysis Bullosa | PHASE3 | Completed | 2023-07-31 |
| NCT04047732 ↗ | Topical KB105 Gene Therapy for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI) TGM-1 Related Autosomal Recessive Congenital Ichthyosis | PHASE1/PHASE2 | Unknown | 2022-10-01 |
| NCT04491604 ↗ | Ph 3 Efficacy and Safety of B-VEC for the Treatment of DEB Dystrophic Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa | PHASE3 | Completed | 2021-10-29 |
| NCT04214002 ↗ | The Natural History of Wounds in Patients With Dystrophic Epidermolysis Bullosa (DEB) Dystrophic Epidermolysis Bullosa, DEB - Dystrophic Epidermolysis Bullosa | — | Withdrawn | 2020-02-24 |
| NCT03536143 ↗ | A Phase I/II Study of KB103, a Topical HSV1-COL7, on DEB Patients Dystrophic Epidermolysis Bullosa | PHASE1/PHASE2 | Completed | 2019-11-01 |
Source: ClinicalTrials.gov (U.S. NIH) · active studies first.
Notable events (8-K)
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-05-20 | 2026-05-15 | 0001711279-26-000047 ↗ |
| 8-K | 2026-05-04 | 2026-05-04 | 0001711279-26-000044 ↗ |
| 10-Q | 2026-05-04 | 2026-03-31 | 0001711279-26-000043 ↗ |
| 8-K | 2026-02-17 | 2026-02-17 | 0001711279-26-000018 ↗ |
| 10-K | 2026-02-17 | 2025-12-31 | 0001711279-26-000016 ↗ |
| 8-K | 2026-01-12 | 2026-01-11 | 0001711279-26-000008 ↗ |
| 8-K | 2026-01-08 | 2026-01-08 | 0001711279-26-000005 ↗ |
| 8-K | 2025-12-23 | 2025-12-23 | 0001711279-25-000092 ↗ |
| 10-Q | 2025-11-03 | 2025-09-30 | 0001711279-25-000087 ↗ |
| 8-K | 2025-11-03 | 2025-11-03 | 0001711279-25-000088 ↗ |
| 8-K | 2025-10-22 | 2025-10-22 | 0001711279-25-000082 ↗ |
| 8-K | 2025-08-04 | 2025-08-04 | 0001711279-25-000078 ↗ |